Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer
Clinical trial NCT04262856 · COMPLETED
Trial details
- NCT number
- NCT04262856
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2025-07-09
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.